Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 296% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 72.3% with 13.7% net margin
- Dividend yield of 2.0%
3M COMPANY (MMM) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $75.2 billion . Key value metrics: P/E ratio 22.1, P/B ratio 15.99, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
3M COMPANY — Fundamental Analysis Summary
3M COMPANY (MMM) is currently trading 296% above its Graham Number of $36.01, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 22.1x.
On financial health, MMM shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 72.3% (sector average: -19.8%), and high leverage with a debt-to-equity ratio of 3.04.
StockPik's composite Value Score for MMM is 55/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MMM reports a solid gross margin of 40.9% (sector average: 33.5%) and a strong operating margin of 20.7%.
MMM shows revenue growing at 2% year-over-year, with earnings declining at 22%.
MMM pays a modest dividend yield of 2.0%.